TomoTherapy completes acquisition of Chinese firm
Madison-based TomoTherapy Inc. on Tuesday announced it has finalized an agreement to acquire privately held linear accelerator manufacturer Chengdu Twin Peak Accelerator Technology Inc., based in Chengdu, China. Terms of the deal were not disclosed.
A linear accelerator (linac) is a key component in radiation therapy systems used to create high-energy X-rays for cancer treatments. The linear accelerators designed, developed and manufactured by Twin Peak will be used to supplement TomoTherapy's existing supply source.
"With the acquisition of Twin Peak, we are reducing our sole supplier risk associated with our linac supply, a critical component to (TomoTherapy's) Hi-Art treatment system," Steve Books, chief operating officer of TomoTherapy, said in a statement. "This acquisition will also expand TomoTherapy's competency in design and manufacturing of linear accelerators which is expected to improve Hi-Art system reliability and positively impact margins."
- Downturn dating: Hearts flutter as markets stutter
- Business Beat: Ending a dysfunctional relationship -- with GM
- Confessions of a Money Manager: July Fourth - halfway mark of a tumultuous year
- Web retailers, states tussle over tax rules
- Sony struggling as once revolutionary Walkman hits 30th anniversary
- Cross Country: Vast collection of farm mementos to be sold
